Letter by Chen et al Regarding Article, "Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial"

Circulation. 2020 Apr 7;141(14):e739-e740. doi: 10.1161/CIRCULATIONAHA.120.045611. Epub 2020 Apr 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Coronary Syndrome* / diagnosis
  • Acute Coronary Syndrome* / drug therapy
  • Clopidogrel / adverse effects
  • Humans
  • Purinergic P2Y Receptor Antagonists / adverse effects
  • Republic of Korea
  • Ticagrelor / adverse effects
  • Ticlopidine / adverse effects

Substances

  • Purinergic P2Y Receptor Antagonists
  • Clopidogrel
  • Ticagrelor
  • Ticlopidine